Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer
Clinical trial NCT02544243 · UNKNOWN
Trial details
- NCT number
- NCT02544243
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.